{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T15:26:57Z","timestamp":1792510017841,"version":"4.5.0"},"reference-count":34,"publisher":"Wiley","issue":"8","license":[{"start":{"date-parts":[[2021,6,3]],"date-time":"2021-06-03T00:00:00Z","timestamp":1622678400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["J of Cosmetic Dermatology"],"published-print":{"date-parts":[[2021,8]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Introduction<\/jats:title><jats:p>Platelet\u2010rich plasma (PRP) is an autologous blood product which has recently been used in multiple spheres of dermatology including facial rejuvenation, androgenetic alopecia, acne scars, and wound healing. Its use in melasma is comparatively an understudied topic.<\/jats:p><\/jats:sec><jats:sec><jats:title>Material and methods<\/jats:title><jats:p>An extensive systematic literature search of the PubMed electronic database and Cochrane central register of controlled trials was done using the keywords \u201cplatelet rich plasma\u201d and \u201cmelasma\u201d in the title. Relevant studies were selected and data were analyzed by two different authors. Four articles were excluded as they did not adhere to the inclusion criteria of this review and a total of 6 articles were reviewed.The relevant references of the included articles were also traced and included.<\/jats:p><\/jats:sec><jats:sec><jats:title>Discussion<\/jats:title><jats:p>These studies showed that PRP has been used effectively not only as an adjuvant therapy but also as a standalone treatment for melasma. PRP contains about 30 growth factors, transforming growth factor beta (TGF\u2010\u03b2) being one of the growth factors having a predominant role in treatment of melasma. TGF\u2010\u03b2 decreases signal transduction of microphthalmia\u2010induced transcription factor and thus decreases tyrosinase and tyrosinase\u2010related proteins. In addition to this, PRP also has an additional benefit of inducing collagen synthesis thus improving the quality and texture of the skin. But there is a scarcity of data and large randomized controlled trials. This review is an effort to highlight and upscale the use of this excellent blood product for melasma which is quite a treatment refractory disorder.<\/jats:p><\/jats:sec>","DOI":"10.1111\/jocd.14229","type":"journal-article","created":{"date-parts":[[2021,5,20]],"date-time":"2021-05-20T04:31:50Z","timestamp":1621485110000},"page":"2431-2436","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Platelet\u2010rich plasma is a promising therapy for melasma"],"prefix":"10.1111","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3110-000X","authenticated-orcid":false,"given":"Ankita","family":"Tuknayat","sequence":"first","affiliation":[{"name":"Department of Dermatology Government Medical College and Hospital Chandigarh India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mala","family":"Bhalla","sequence":"additional","affiliation":[{"name":"Department of Dermatology Government Medical College and Hospital Chandigarh India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gurvinder Pal","family":"Thami","sequence":"additional","affiliation":[{"name":"Department of Dermatology Government Medical College and Hospital Chandigarh India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2021,6,3]]},"reference":[{"key":"e_1_2_9_2_1","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.143.3.424"},{"key":"e_1_2_9_3_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-4362.1998.00585.x"},{"key":"e_1_2_9_4_1","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-61-1-28"},{"key":"e_1_2_9_5_1","doi-asserted-by":"publisher","DOI":"10.4103\/0019-5154.84722"},{"key":"e_1_2_9_6_1","doi-asserted-by":"publisher","DOI":"10.2165\/00044011-199500102-00006"},{"key":"e_1_2_9_7_1","first-page":"753","article-title":"Topical trenaxamic acid as a promising treatment for melasma","volume":"19","author":"Ebrahimi B","year":"2014","journal-title":"J Res Med Sci"},{"key":"e_1_2_9_8_1","first-page":"124","article-title":"Topical tranexamic acid with microneedling in melasma","volume":"3","author":"Kaur A","year":"2019","journal-title":"Acta Sci Med Sci"},{"key":"e_1_2_9_9_1","doi-asserted-by":"publisher","DOI":"10.1177\/039139888701000111"},{"key":"e_1_2_9_10_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.prs.0000239606.92676.cf"},{"key":"e_1_2_9_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.arthro.2011.10.018"},{"key":"e_1_2_9_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.joms.2003.12.003"},{"key":"e_1_2_9_13_1","first-page":"155","article-title":"Platelet rich plasma in dermatology","volume":"5","author":"Monteiro MR","year":"2013","journal-title":"Surg Cosmet Dermatol"},{"key":"e_1_2_9_14_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1524-4725.2012.02394.x"},{"key":"e_1_2_9_15_1","doi-asserted-by":"publisher","DOI":"10.1097\/DSS.0000000000001965"},{"key":"e_1_2_9_16_1","doi-asserted-by":"publisher","DOI":"10.1097\/DSS.0000000000001894"},{"issue":"5","key":"e_1_2_9_17_1","first-page":"CD006899","article-title":"Autologous platelet\u2010rich plasma for treating chronic wounds","author":"Martinez\u2010Zapata MJ","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_9_18_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1524-4725.2011.02280.x"},{"key":"e_1_2_9_19_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1524-4725.2011.01999.x"},{"key":"e_1_2_9_20_1","unstructured":"International Cellular Medicine Society Guidelines for PRP. Section 10 2011 Accessed fromhttp:\/\/www.cellmedicinesociety.org\/attachments\/370_Section%2010%20\u2010%20Platelet%20Rich%20Plasma%20(PRP)%20Guidelines.pdf. Last accessed on 29th May 2020."},{"key":"e_1_2_9_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biocel.2003.10.023"},{"key":"e_1_2_9_22_1","doi-asserted-by":"publisher","DOI":"10.4103\/0974-2077.150734"},{"key":"e_1_2_9_23_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.oto.2012.01.004"},{"key":"e_1_2_9_24_1","doi-asserted-by":"publisher","DOI":"10.1097\/DSS.0000000000001049"},{"issue":"1","key":"e_1_2_9_25_1","first-page":"S102","article-title":"A new simplified technique for producing platelet\u2010rich plasma: a short technical note","author":"Marlovits S","year":"2014","journal-title":"Eur Spine J"},{"key":"e_1_2_9_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2008.11.002"},{"key":"e_1_2_9_27_1","doi-asserted-by":"publisher","DOI":"10.1111\/dsu.12348"},{"key":"e_1_2_9_28_1","first-page":"87","article-title":"Treatment of periorbital hyperpigmentation using platelet\u2010rich plasma injections","volume":"3","author":"Al\u2010Shami SH","year":"2014","journal-title":"Am J Dermatol Venereol"},{"key":"e_1_2_9_29_1","doi-asserted-by":"publisher","DOI":"10.4161\/derm.21923"},{"key":"e_1_2_9_30_1","doi-asserted-by":"publisher","DOI":"10.1111\/dth.14881"},{"key":"e_1_2_9_31_1","doi-asserted-by":"publisher","DOI":"10.5021\/ad.2014.26.3.401"},{"key":"e_1_2_9_32_1","first-page":"1","article-title":"Response to intradermal autologous platelet rich plasma injection in refractory dermal melasma: report of two cases","volume":"18","author":"Yew CH","year":"2015","journal-title":"JUMMEC"},{"key":"e_1_2_9_33_1","doi-asserted-by":"publisher","DOI":"10.1080\/09546634.2018.1524821"},{"key":"e_1_2_9_34_1","doi-asserted-by":"publisher","DOI":"10.1111\/jocd.13157"},{"key":"e_1_2_9_35_1","doi-asserted-by":"publisher","DOI":"10.1080\/09546634.2020.1781755"}],"container-title":["Journal of Cosmetic Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jocd.14229","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/jocd.14229","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jocd.14229","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,29]],"date-time":"2023-08-29T19:46:22Z","timestamp":1693338382000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/jocd.14229"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,3]]},"references-count":34,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["10.1111\/jocd.14229"],"URL":"https:\/\/doi.org\/10.1111\/jocd.14229","archive":["Portico"],"relation":{},"ISSN":["1473-2130","1473-2165"],"issn-type":[{"value":"1473-2130","type":"print"},{"value":"1473-2165","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,3]]},"assertion":[{"value":"2021-03-16","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-04-12","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-06-03","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}